Can I read Oklahoma Innovator Develops Exoskeletons on EtoBox?
Oklahoma Innovator Develops Exoskeletons by Price Lang is a document available to read on EtoBox.
What is Oklahoma Innovator Develops Exoskeletons about?
The document summarizes the lengthy process of developing the drug Soliris to treat the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH). It took 18 years from the initial discoveries at the Oklahoma Medical Research Foundation in 1989 to develop Soliris and receive FDA approval in 2007. The lengthy process included humanizing the antibody discovered by OMRF scientists, rigorous preclinical and clinical testing involving many patients over many years, and high costs averaging in the hundreds of
- Author
- Price Lang
- Language
- EN